NPS Pharmaceuticals Jumps On Study On Short Bowel Syndrome Drug

NPS Pharmaceuticals (NPSP) has raced higher throughout most of the first three hours of trading. The buying interest comes after the company initiated a phase 3 “STEPS” study to confirm GATTEX reduces paternal nutrition dependence in short bowel syndrome.

• Welcome to FX Market

  • The Company
  • Forex Broker
  • Performance & Fees
  • Funds Deposit/Withdrawal
  • Hedge Funds Vs Managed accounts
  • Capital Protected Account
  • Safety of Funds
  • Risk Disclaimer
  • Contact Us

• Advertisment

  

Copyright © 2007-2009 Invest2forex.com. Important. Trading foreign exchange on margin carries a high level of risk, and may not be suitable for all investors. Before deciding to invest in foreign exchange you should carefully consider your investment objectives, level of experience, and risk appetite. Hypothetical performance results have many inherent limitations, some of which are described below. No representation is being made that any managed account will or is likely to achieve profits or losses similar to those shown. In fact, there are frequently sharp differences between hypothetical performance results and the actual results subsequently achieved by any particular forex trading program. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk in actual online trading. Past performance does not guarantee future results. All funds are held with properly regulated forex broker. Market News headlines are powered by DailyFX.com

forex currency trading forex managed accounts